Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5784
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHanuscheck, Nicholas-
dc.contributor.authorSchnatz, Andrea-
dc.contributor.authorThalman, Carine-
dc.contributor.authorLerch, Steffen-
dc.contributor.authorGärtner, Yvonne-
dc.contributor.authorDomingues, Micaela-
dc.contributor.authorBitar, Lynn-
dc.contributor.authorNitsch, Robert-
dc.contributor.authorZipp, Frauke-
dc.contributor.authorVogelaar, Christina F.-
dc.date.accessioned2021-05-03T10:35:15Z-
dc.date.available2021-05-03T10:35:15Z-
dc.date.issued2020-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/5793-
dc.description.abstractNeurons of the central nervous system (CNS) that project long axons into the spinal cord have a poor axon regenerative capacity compared to neurons of the peripheral nervous system. The corticospinal tract (CST) is particularly notorious for its poor regeneration. Because of this, traumatic spinal cord injury (SCI) is a devastating condition that remains as yet uncured. Based on our recent observations that direct neuronal interleukin-4 (IL-4) signaling leads to repair of axonal swellings and beneficial effects in neuroinflammation, we hypothesized that IL-4 acts directly on the CST. Here, we developed a tissue culture model for CST regeneration and found that IL-4 promoted new growth cone formation after axon transection. Most importantly, IL-4 directly increased the regenerative capacity of both murine and human CST axons, which corroborates its regenerative effects in CNS damage. Overall, these findings serve as proof-of-concept that our CST regeneration model is suitable for fast screening of new treatments for SCI.en_GB
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleGrowth-promoting treatment screening for corticospinal neurons in mouse and manen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-5784-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleCellular and molecular neurobiologyde
jgu.journal.volume40de
jgu.pages.start1327de
jgu.pages.end1338de
jgu.publisher.year2020-
jgu.publisher.nameSpringer Science + Business Media B.Vde
jgu.publisher.placeDordrechtde
jgu.publisher.urihttps://doi.org/10.1007/s10571-020-00820-7de
jgu.publisher.issn1573-6830de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1007/s10571-020-00820-7
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
hanuscheck_nicholas-growth-promoti-20210420205909752.pdf9.3 MBAdobe PDFView/Open